Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington’s Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaoxia Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China. Hauptthemen laut MEDLINE: Huntington Disease, Huntingtin Protein, Protein Processing, Post-Translational. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Huntingtin (HTT) is a large, ubiquitously expressed scaffold protein that participates in multiple cellular processes, including vesicular transport, transcriptional regulation, and energy metabolism. The mutant form of HTT (mHTT), characterized by an abnormal polyglutamine (polyQ) expansion in its N-terminal region, is the causative agent of Huntington’s disease (HD), a progressive neurodegenerative disorder. Current therapeutic efforts for HD have primarily focused on lowering HTT levels through gene silencing or promoting mHTT degradation. However, accumulating evidence suggests that post-translational modifications (PTMs) of HTT—such as phosphorylation, ubiquitination, acetylation, and SUMOylation—play pivotal roles in modulating HTT’s conformation, aggregation propensity, subcellular localization, and degradation pathways. These modifications regulate the balance between HTT’s physiological functions and pathological toxicity. Importantly, dysregulation of PTMs has been linked to mHTT accumulation and selective neuronal vulnerability, highlighting their relevance as potential therapeutic targets. A deeper understanding of how individual PTMs and their crosstalk regulate HTT homeostasis may not only provide mechanistic insights into HD pathogenesis but also uncover novel, more specific strategies for intervention. In this review, we summarize recent understanding on HTT PTMs, discuss their implications for disease modification, and outline critical knowledge gaps that remain to be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zhang, S., & Wang, C. (2025). Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210907
Vancouver
Zhang X, Zhang S, Wang C. Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210907
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoxia and Zhang, Shengping and Wang, Chuangui},
title = {Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210907}
}
EUVIMED